Matthias Hebben
Chief Tech/Sci/R&D Officer at LOGICBIO THERAPEUTICS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frédéric Chéreau | M | 57 | 8 years | |
| Jonathan Quick | M | - | 5 years | |
| Marie Payton | F | - | 5 years | |
| Michael Franken | M | 59 | 3 years | |
| Alexandre Lemoalle | M | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 9 years |
| Janice Olson | F | - | 3 years | |
| Sven Loebrich | M | - | - | |
| Grace Lochhead | F | - | 3 years | |
| David E. White | M | - | - | |
| Tom Wilton | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cecilia Jones | F | 49 | 1 years | |
| Bryan Yoon | M | 47 | 1 years | |
| Mark A. Kay | M | 66 | 8 years | |
| Richard A. Moscicki | M | 72 | 4 years | |
| Michael Wyzga | M | 69 | 4 years | |
| Leon E. Chen | M | 49 | 6 years | |
| Susan R. Kahn | F | 67 | 1 years | |
| Andrea Paul | F | 43 | - | |
| Kyle Chiang | M | 44 | 5 years | |
| Daniel O’Connell | M | 44 | 3 years | |
| Sofia Ioannidou | M | 45 | 2 years | |
| Erez Chimovits | M | 60 | 4 years | |
| Cem Meric | M | - |
University of Strasbourg
| 5 years |
| Brian Luque | M | - | - | |
| J. Goater | M | 48 | 2 years | |
| Daphne Karydas | F | 49 | 2 years | |
| Michel Gréco | M | 80 | 4 years | |
| Tomer Kariv | M | 62 | 3 years | |
| Alain Munoz | M | 75 | - | |
| Joshua Blacher | M | 52 | - | |
| Matthias B. Jaffé | M | 50 | 3 years | |
| Mark Enyedy | M | 60 | 2 years | |
| Valerie Salentey | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 2 years |
| Michael Moser | M | - |
University of Strasbourg
| 4 years |
| Yael Hayon | M | 41 | 4 years | |
| Daniel J. Gruskin | M | 52 | 2 years | |
| Sandrine Braud | M | - |
University of Strasbourg
| 3 years |
| Hansjörg Sage | M | - |
University of Strasbourg
| 3 years |
| Peter Pechan | M | - | - | |
| Stephen Boyer | M | - | 1 years | |
| Vincent Ricchiuti | M | - |
University of Strasbourg
| 3 years |
| Nelson Chau | M | - | 4 years | |
| David Martial | M | - |
University of Nice Sophia Antipolis
| 4 years |
| Federico Mingozzi | M | 50 |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 4 years |
| Elisabeth Leize | M | - |
University of Strasbourg
| 3 years |
| Gaël Hédou | M | 52 |
University of Strasbourg
| 4 years |
| Fulvio Mavilio | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 5 years |
| Mariana Nacht | M | 60 | 2 years | |
| Humberto Andrés Fuenzalida Etcheverry | M | 60 |
University of Strasbourg
| 3 years |
| Sandra E. Poole | F | 60 | 1 years | |
| Frédéric Grimaud | M | 59 | 11 years | |
| George Li | M | - |
University of Strasbourg
| 1 years |
| Volker Berl | M | 51 |
University of Strasbourg
| 3 years |
| Kenneth Huttner | M | - | 1 years | |
| Imad Zoghlami | M | - |
University of Nice Sophia Antipolis
| 3 years |
| Neal Gordon Simon | M | - |
University of Strasbourg
| - |
| Etienne Simonnet | M | - |
University of Strasbourg
| 1 years |
| Paul Herzich | M | 46 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 37 | 63.79% |
| France | 21 | 36.21% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Matthias Hebben
- Personal Network
